Evidence map›Paper›PMID 35205801›Full record

ArticleCancers2022

TLR4 and pSTAT3 Expression on Circulating Tumor Cells (CTCs) and Immune Cells in the Peripheral Blood of Breast Cancer Patients: Prognostic Implications.

Maria A Papadaki, Alexia Monastirioti, Christina A Apostolopoulou, Despoina Aggouraki, Chara Papadaki, Kleita Michaelidou, Maria Vassilakopoulou, Katerina Alexakou, Dimitrios Mavroudis, Sofia Agelaki

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Maria A PapadakiLaboratory of Translational Oncology, School of Medicine, University of Crete, 71110 Heraklion, Greece.ORCID 0000-0002-6363-7258
Alexia MonastiriotiLaboratory of Translational Oncology, School of Medicine, University of Crete, 71110 Heraklion, Greece.
Christina A ApostolopoulouLaboratory of Translational Oncology, School of Medicine, University of Crete, 71110 Heraklion, Greece.
Despoina AggourakiLaboratory of Translational Oncology, School of Medicine, University of Crete, 71110 Heraklion, Greece.
Chara PapadakiLaboratory of Translational Oncology, School of Medicine, University of Crete, 71110 Heraklion, Greece.ORCID 0000-0002-4591-3757
Kleita MichaelidouLaboratory of Translational Oncology, School of Medicine, University of Crete, 71110 Heraklion, Greece.
Maria VassilakopoulouLaboratory of Translational Oncology, School of Medicine, University of Crete, 71110 Heraklion, Greece.
Katerina AlexakouLaboratory of Translational Oncology, School of Medicine, University of Crete, 71110 Heraklion, Greece.
Dimitrios MavroudisLaboratory of Translational Oncology, School of Medicine, University of Crete, 71110 Heraklion, Greece.
Sofia AgelakiLaboratory of Translational Oncology, School of Medicine, University of Crete, 71110 Heraklion, Greece.
University of Crete · GR

Funding

Anticancer Research Support Association (ARSA) Research grants_2017Hellenic Society of Medical Oncology (HESMO) Research grants.2021
6 · The paper itself

Abstract

TLR4 and pSTAT3 are key players in cancer inflammation and immune evasion; however, their role in the peripheral blood (PB) is largely unexplored. Herein we evaluated their expression in the circulating tumor cells (CTCs) and peripheral-blood mononuclear cells (PBMCs) of patients with early (

Indexed as

breast cancercancer inflammationcirculating tumor cells (CTCs)immune cellsimmune evasionliquid biopsyperipheral-blood mononuclear cells (PBMCs)peripheral immune responsephosphorylated signal transducer and activator of transcription protein 3 (pSTAT3)toll-like receptor 4 (TLR4)

Identifiers

PMID35205801
PMCPMC8869985
OpenAlexW4213109765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.